{"id":449860,"date":"2025-12-31T00:30:00","date_gmt":"2025-12-30T23:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/les-options-therapeutiques-medicamenteuses-ont-le-vent-en-poupe-des-preuves-spectaculaires\/"},"modified":"2025-12-30T23:25:17","modified_gmt":"2025-12-30T22:25:17","slug":"les-options-therapeutiques-medicamenteuses-ont-le-vent-en-poupe-des-preuves-spectaculaires","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/les-options-therapeutiques-medicamenteuses-ont-le-vent-en-poupe-des-preuves-spectaculaires\/","title":{"rendered":"Les options th\u00e9rapeutiques m\u00e9dicamenteuses ont le vent en poupe : des preuves spectaculaires"},"content":{"rendered":"\n

Au cours des derni\u00e8res d\u00e9cennies, la fr\u00e9quence des maladies st\u00e9atosiques du foie a augment\u00e9 parall\u00e8lement \u00e0 l’augmentation de l’ob\u00e9sit\u00e9, du diab\u00e8te et d’autres maladies m\u00e9taboliques. Il est recommand\u00e9 de proc\u00e9der \u00e0 un d\u00e9pistage cibl\u00e9 des patients \u00e0 risque. Des progr\u00e8s consid\u00e9rables ont \u00e9t\u00e9 r\u00e9alis\u00e9s r\u00e9cemment. Des \u00e9tudes r\u00e9centes ont identifi\u00e9 des sous-types de MASLD pr\u00e9sentant diff\u00e9rents profils de risque cardiovasculaire. Dans le domaine du traitement m\u00e9dicamenteux de la MASH, une perc\u00e9e importante a \u00e9t\u00e9 r\u00e9alis\u00e9e avec l’approbation du resmetirom par la FDA et l’EMA. Mais les donn\u00e9es sur le semaglutide administr\u00e9 par voie sous-cutan\u00e9e sont \u00e9galement prometteuses, comme le montrent des analyses int\u00e9rimaires r\u00e9centes. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Au cours des derni\u00e8res d\u00e9cennies, la fr\u00e9quence des maladies st\u00e9atosiques du foie a augment\u00e9 parall\u00e8lement \u00e0 l’augmentation de l’ob\u00e9sit\u00e9, du diab\u00e8te et d’autres maladies m\u00e9taboliques. Il est recommand\u00e9 de proc\u00e9der……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":449863,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"MASLD\/MASH ","footnotes":""},"category":[11527,11414,11315,11535,11549],"tags":[24770,83702,77501,45657,87012,77503,17458],"powerkit_post_featured":[],"class_list":["post-449860","post","type-post","status-publish","format-standard","has-post-thumbnail","category-etudes","category-gastro-enterologie-et-hepatologie","category-medecine-interne-generale","category-rapports-de-congres","category-rx-fr","tag-maladies-du-foie","tag-mash-fr-2","tag-masld-fr","tag-nash-fr","tag-options-therapeutiques-medicamenteuses","tag-resmetirom-fr","tag-semaglutid-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-02 16:51:53","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":449856,"slug":"opzioni-di-terapia-farmacologica-in-aumento-prove-spettacolari","post_title":"Opzioni di terapia farmacologica in aumento: prove spettacolari","href":"https:\/\/medizinonline.com\/it\/opzioni-di-terapia-farmacologica-in-aumento-prove-spettacolari\/"},"pt_PT":{"locale":"pt_PT","id":449852,"slug":"opcoes-de-terapia-medicamentosa-em-ascensao-provas-espectaculares","post_title":"Op\u00e7\u00f5es de terapia medicamentosa em ascens\u00e3o: provas espectaculares","href":"https:\/\/medizinonline.com\/pt-pt\/opcoes-de-terapia-medicamentosa-em-ascensao-provas-espectaculares\/"},"es_ES":{"locale":"es_ES","id":449849,"slug":"aumentan-las-opciones-de-tratamiento-farmacologico-pruebas-espectaculares","post_title":"Aumentan las opciones de tratamiento farmacol\u00f3gico: pruebas espectaculares","href":"https:\/\/medizinonline.com\/es\/aumentan-las-opciones-de-tratamiento-farmacologico-pruebas-espectaculares\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/449860","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=449860"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/449860\/revisions"}],"predecessor-version":[{"id":460298,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/449860\/revisions\/460298"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/449863"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=449860"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=449860"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=449860"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=449860"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}